Abstract:
Aim: The aim of this study was to see how well a new bioabsorbable vascular closure device (VCD) performs in comparison with manual compression (MC) for access-site hemostasis in patients undergoing percutaneous peripheral procedures. Material and Methods: This retrospective cohort study was carried out by examining the files of patients who underwent vascular intervention for peripheral artery disease at Ordu University Training and Research Hospital between February 1, 2019, and January 31, 2020. The cases were divided into two groups according to the method of achieving access-site hemostasis (MC or VCD). Results: The patients' mean age was 64.81 +/- 11.03 years, and 75.3% were males. There were 41 cases in the MC group and 40 cases in the VCD group. The frequency of hyperlipidemia in the VCD group was significantly higher than in the MC group (65.0% vs. 31.7%, p = 0.003). Time to hemostasis (TTH), time to ambulation (TTA), and length of hospital stay were significantly greater in the MC group than in the VCD group (p<0.001 for all). No major complications were observed in the VCD group, whereas 5 (6.2%) patients in the MC group developed complications (p = 0.023). Discussion: The use of VCD appears to be associated with shorter TTH, TTA, and length of hospital stay, and major complications were less frequent in the VCD group.